Poonam Na Bai

Poonam Bai practices at Penn State Health Milton S. Hershey Medical Center in Hershey, Pennsylvania, part of Penn State.

Poonam Bai's NPI, 1023503604, was assigned on June 26, 2018. Poonam Bai holds Pennsylvania license MD482740.

Poonam Bai's primary practice is Penn State Health Milton S. Hershey Medical Center, at 500 University Drive, Hershey, PA 17033 in Dauphin County. The practice phone is (717) 531-8521.

Poonam Bai's primary practice is Penn State Health Milton S. Hershey Medical Center in Hershey, Pennsylvania, part of Penn State. Poonam Bai is also affiliated with Penn State Health Holy Spirit Medical Center. The medical group on file is Penn State Health Milton S. Hershey Medical Center. Dmand AI also links Poonam Bai to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Poonam Bai practices, 2 sites in all. Vendor and product names are available with a free account.

Infectious disease is Poonam Bai's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Poonam Bai is board certified in infectious disease by the American Board of Internal Medicine. Dmand AI has Poonam Bai's licenses on file in 2 states: Pennsylvania and Michigan.

CMS data shows 203 Medicare services from Poonam Bai across 6 procedure codes in 2024, for 95 Medicare patients. Medicare paid $15,270 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 95 Medicare patients who saw Poonam Bai in 2024. The largest group is 65 to 74, with 44 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 13% are also on Medicaid. Their average risk score is 2.54, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Poonam Bai's median patient age at 69, with 46% women.

In 2024, Poonam Bai wrote 295 Medicare Part D claims for 89 patients. 92% of them were for generic drugs. CMS names the drug for 217 of them, across 11 drugs with 11 or more claims each, at $36,405 in total drug cost. In 2022, CMS named 85 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Poonam Bai for performance year 2024, reported as part of a group. Poonam Bai accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 2 papers to Poonam Bai, published from 2024 to 2025. Poonam Bai's most frequent co-authors are Arjan Dass, MD, Aakash Kumar, MD and John D. Randolph, MD.

CMS Open Payments shows 4 general payments to Poonam Bai from 4 drug and device companies from 2018 to 2024. Food and beverage make up the largest share, 100% of the total. Paratek Pharmaceuticals, Inc. paid the most, $77.